Nkarta initiates clinical trial of nkx019 in lupus nephritis with first patient in screening and announces pipeline expansion to additional autoimmune indications

Patient screening underway in ntrust-1, the first u.s.-based clinical trial of an engineered nk cell therapy for the treatment of lupus nephritis

NKTX Ratings Summary

NKTX Quant Ranking